Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
INDP
Valuation N/A
Indaptus Therapeutics, Inc.
Price$2.51
Model IV—
P/IV—
Limited data — see page
INEO
Deeply undervalued
INNEOVA Holdings Ltd
Price$0.55
Model IV$1.76
P/IV0.29
Discount 69%
Return to IV: +222.0%
Market implies -18.8%/yr
vs model +5.5% · below model
INFU
Deeply overvalued
InfuSystem Holdings, Inc
Price$13.56
Model IV$10.28
P/IV0.88
Premium +32%
Return to IV: -24.2%
Market implies +10.1%/yr
vs model +10.3% · in line
INGN
Deeply undervalued
Inogen Inc
Price$6.18
Model IV$9.60
P/IV0.68
Discount 36%
Return to IV: +55.3%
Market implies -10.3%/yr
vs model +2.0% · below model
INHD
Valuation N/A
INNO HOLDINGS INC.
Price$3.75
Model IV—
P/IV—
Market implies +41.6%/yr
vs model +0.0% · above model
INKT
Valuation N/A
MiNK Therapeutics, Inc.
Price$10.72
Model IV—
P/IV—
Limited data — see page
INLF
Deeply undervalued
INLIF Ltd
Price$3.02
Model IV$5.27
P/IV0.72
Discount 43%
Return to IV: +74.3%
Market implies -18.2%/yr
vs model +40.4% · below model
INLX
Deeply undervalued
INTELLINETICS, INC.
Price$4.78
Model IV$12.61
P/IV0.50
Discount 62%
Return to IV: +163.8%
Market implies -25.1%/yr
vs model +9.7% · below model
INM
Deeply undervalued
InMed Pharmaceuticals Inc.
Price$1.36
Model IV$11.60
P/IV0.14
Discount 88%
Return to IV: +752.6%
Market implies -48.8%/yr
vs model +26.9% · below model
INMB
Valuation N/A
Inmune Bio, Inc.
Price$1.89
Model IV—
P/IV—
Market implies +120.1%/yr
vs model +2.0% · above model
INO
Valuation N/A
INOVIO PHARMACEUTICALS, INC.
Price$1.15
Model IV—
P/IV—
Market implies +100.1%/yr
vs model +2.0% · above model
INSE
Fairly valued
Inspired Entertainment, Inc.
Price$3.75
Model IV$4.37
P/IV1.03
Discount 14%
Return to IV: +16.5%
Market implies +2.9%/yr
vs model +9.1% · below model
INSG
Deeply undervalued
INSEEGO CORP.
Price$4.58
Model IV$7.80
P/IV1.68
Discount 41%
Return to IV: +70.4%
Market implies -5.1%/yr
vs model +2.0% · below model
INTG
Deeply overvalued
INTERGROUP CORP
Price$32.17
Model IV$20.31
P/IV1.91
Premium +58%
Return to IV: -36.9%
INTJ
Undervalued
Intelligent Group Ltd
Price$2.93
Model IV$3.51
P/IV2.71
Discount 17%
Return to IV: +19.8%
Market implies -13.7%/yr
vs model +15.0% · below model
INTS
Valuation N/A
INTENSITY THERAPEUTICS, INC.
Price$3.63
Model IV—
P/IV—
Limited data — see page
INTT
Deeply overvalued
INTEST CORP
Price$14.55
Model IV$4.63
P/IV3.64
Premium +214%
Return to IV: -68.2%
Market implies +20.5%/yr
vs model +8.3% · above model
INTZ
Valuation N/A
INTRUSION INC
Price$0.66
Model IV—
P/IV—
Market implies +37.1%/yr
vs model +2.0% · above model
INUV
Deeply undervalued
Inuvo, Inc.
Price$0.52
Model IV$6.15
P/IV0.10
Discount 92%
Return to IV: +1,091.9%
Market implies -50.0%/yr
vs model +9.6% · below model
INV
Valuation N/A
Innventure, Inc.
Price$0.27
Model IV—
P/IV—
Market implies +18.8%/yr
INVE
Deeply overvalued
Identiv, Inc.
Price$2.42
Model IV$0.87
P/IV4.73
Premium +179%
Return to IV: -64.2%
Market implies +10.0%/yr
vs model +2.0% · above model
INVZ
Deeply overvalued
Innoviz Technologies Ltd.
Price$0.31
Model IV$0.09
P/IV4.80
Premium +262%
Return to IV: -72.4%
Market implies +23.4%/yr
vs model +8.0% · above model
IOR
Deeply overvalued
INCOME OPPORTUNITY REALTY INVESTORS INC /TX/
Price$17.15
Model IV$4.95
P/IV3.69
Premium +247%
Return to IV: -71.2%
IOTR
Undervalued
iOThree Ltd
Price$1.95
Model IV$2.57
P/IV1.52
Discount 24%
Return to IV: +31.6%
Market implies -3.1%/yr
vs model +50.0% · below model
IPB
Valuation N/A
MERRILL LYNCH DEPOSITOR INC INDEXPLUS TRUST SERIES 2003-1
Price$25.00
Model IV—
P/IV—
Limited data — see page
IPCX
Valuation N/A
Inflection Point Acquisition Corp. III
Price$3.95
Model IV—
P/IV—
Limited data — see page
IPCXR
Valuation N/A
Inflection Point Acquisition Corp. III
Price$0.39
Model IV—
P/IV—
Limited data — see page
IPCXU
Valuation N/A
IPCXU
Price$5.80
Model IV—
P/IV—
Limited data — see page
IPDN
Valuation N/A
Professional Diversity Network, Inc.
Price$3.53
Model IV—
P/IV—
Market implies +22.9%/yr
IPEX
Valuation N/A
Inflection Point Acquisition Corp. V
Price$3.16
Model IV—
P/IV—
Limited data — see page
IPEXR
Valuation N/A
Inflection Point Acquisition Corp. V
Price$0.60
Model IV—
P/IV—
Limited data — see page
IPEXU
Valuation N/A
Inflection Point Acquisition Corp. V
Price$3.54
Model IV—
P/IV—
Limited data — see page
IPFX
Valuation N/A
Inflection Point Acquisition Corp. VI
Price$10.05
Model IV—
P/IV—
Limited data — see page
IPFXU
Valuation N/A
Inflection Point Acquisition Corp. VI
Price$10.40
Model IV—
P/IV—
Limited data — see page
IPFXW
Valuation N/A
Inflection Point Acquisition Corp. VI
Price$0.76
Model IV—
P/IV—
Limited data — see page
IPHA
Valuation N/A
Innate Pharma SA
Price$1.62
Model IV—
P/IV—
Limited data — see page
IPM
Deeply overvalued
INTELLIGENT PROTECTION MANAGEMENT CORP.
Price$1.77
Model IV$0.38
P/IV4.72
Premium +363%
Return to IV: -78.4%
Market implies +28.5%/yr
vs model +12.7% · above model
IPOD
Valuation N/A
COLLECTIVE ACQUISITION CORP.
Price$10.45
Model IV—
P/IV—
Limited data — see page
IPODU
Valuation N/A
IPODU
Price$10.68
Model IV—
P/IV—
Limited data — see page
IPODW
Valuation N/A
IPODW
Price$0.28
Model IV—
P/IV—
Limited data — see page
IPST
Valuation N/A
IP STRATEGY HOLDINGS, INC.
Price$3.01
Model IV—
P/IV—
Market implies +39.0%/yr
vs model +12.7% · above model
IPW
Valuation N/A
iPower Inc.
Price$0.68
Model IV—
P/IV—
Market implies +112.7%/yr
IPWR
Valuation N/A
Ideal Power Inc.
Price$3.61
Model IV—
P/IV—
Market implies +115.0%/yr
vs model +2.0% · above model
IQ
Valuation N/A
iQIYI, Inc.
Price$1.02
Model IV—
P/IV—
Market implies +30.1%/yr
IQST
Valuation N/A
iQSTEL Inc
Price$1.04
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +48.8% · below model
IRAB
Valuation N/A
Iris Acquisition Corp II
Price$10.01
Model IV—
P/IV—
Limited data — see page
IRHO
Valuation N/A
Iron Horse Acquisition II Corp.
Price$10.06
Model IV—
P/IV—
Limited data — see page
IRHOR
Valuation N/A
Iron Horse Acquisition II Corp.
Price$0.17
Model IV—
P/IV—
Limited data — see page
IRHOU
Valuation N/A
Iron Horse Acquisition II Corp.
Price$10.16
Model IV—
P/IV—
Limited data — see page
IRIX
Deeply undervalued
IRIDEX CORP
Price$0.89
Model IV$1.72
P/IV0.37
Discount 48%
Return to IV: +93.0%
Market implies -13.3%/yr
vs model +2.0% · below model
ISBA
Deeply overvalued
ISABELLA BANK CORP
Price$37.29
Model IV$24.83
P/IV1.50
Premium +50%
Return to IV: -33.4%
ISD
Valuation N/A
PGIM High Yield Bond Fund, Inc.
Price$11.70
Model IV—
P/IV—
Limited data — see page
ISPC
Valuation N/A
iSpecimen Inc.
Price$1.13
Model IV—
P/IV—
Market implies +19.9%/yr
vs model +2.0% · above model
ISPR
Deeply overvalued
Ispire Technology Inc.
Price$1.52
Model IV$0.71
P/IV2.02
Premium +113%
Return to IV: -53.0%
Market implies +7.6%/yr
vs model +2.2% · above model
ITHA
Valuation N/A
ITHAX Acquisition Corp III
Price$10.06
Model IV—
P/IV—
Limited data — see page
ITHAU
Valuation N/A
ITHAX Acquisition Corp III
Price$10.13
Model IV—
P/IV—
Limited data — see page
ITHAW
Valuation N/A
ITHAX Acquisition Corp III
Price$0.18
Model IV—
P/IV—
Limited data — see page
ITOC
Valuation N/A
iTonic Holdings Ltd
Price$4.07
Model IV—
P/IV—
Market implies +104.5%/yr
vs model +2.0% · above model
ITP
Valuation N/A
IT TECH PACKAGING, INC.
Price$0.15
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +1.4% · below model
IVDA
Deeply undervalued
Iveda Solutions, Inc.
Price$0.27
Model IV$1.70
P/IV0.23
Discount 84%
Return to IV: +523.2%
Market implies -37.5%/yr
vs model +28.8% · below model
